Using lab-grown cancer models to guide liver cancer treatment
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether using a lab-grown 'mini-tumor' (organoid) made from your cancer cells can help pick a more effective treatment for liver cancer that can't be removed with surgery. The goal is to find a drug that works specifically for your cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You need a confirmed diagnosis of primary liver cancer.
- Your liver function should be fairly good (Child-Pugh class A or early B).
- You should be able to perform daily activities with some help (ECOG 0 or 1).
- You should not have had radiation therapy in the last 3 months.
- Your blood cell counts, liver, kidney, and clotting function need to be within acceptable ranges.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with advanced liver cancer that cannot be treated with surgery. It aims to gather information about the disease and how it is managed, which could help improve future care.
This trial uses a test on your tumor (an 'organoid') to pick which medicines might work best for you after surgery. The goal is to lower the chance of your liver cancer coming back.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
This study uses tumor samples to create lab-grown mini-livers (organoids) to better understand liver cancer. It may help researchers learn more about the disease and develop new treatments.
This trial tests new treatment plans for people with advanced liver cancer that has worsened after initial therapy. The goal is to find more effective, personalized options based on how your cancer responds.
This study is testing whether combining targeted therapy with immunotherapy (or using two immunotherapies together) can help people with liver cancer that cannot be surgically removed. The goal is to understand how well these treatments work and how they affect biomarkers (signals in your body that show treatment response).
Hear when a new Unresectable Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.